Professional Documents
Culture Documents
Nontuberculous Mycobacterial
Infections 7th Edition
Visit to download the full and correct content document:
https://ebooksecure.com/download/ebook-pdf-tuberculosis-and-nontuberculous-myco
bacterial-infections-7th-edition/
Contents
Contributors xi
Preface xxi
I. General Considerations
vii
viii Contents
11. Mycobacterium bovis BCG and New Vaccines for the Prevention
of Tuberculosis 187
Timothy Lahey and C. Fordham Von Reyn
II. Clinical Syndromes
III. Nontuberculous Mycobacteria
Index 777
Contributors
Ritesh Agarwal
Department of Pulmonary Medicine
Postgraduate Institute of Medical Education & Research
Chandigarh, India
José M. Aguado
University Hospital 12 de Octubre
Unit of Infectious Diseases
Madrid, Spain
Daniel M. Albert
Department of Ophthalmology and Visual Sciences
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin
Stephen C. Aronoff
Department of Pediatrics
Lewis Katz School of Medicine
Temple University
Philadelphia, Pennsylvania
Alexandra Aubry
Centre National de Référence pour la résistance des Mycobactéries aux
antituberculeux
Sorbonne Université
Université Pierre et Marie Curie
AP-HP Hôpital Pitié-Salpêtrière
Centre d’Immunologie et des Maladies Infectieuses, Team 13, INSERM U1135
Paris, France
xi
xii Contributors
Shyam S. Balepur
ABBCI, Division of Hematology & Oncology
Penn Medicine/Lancaster General Health
Lancaster, Pennsylvania
Marvin J. Bittner
Infectious Diseases Section
VA Medical Center
Departments of Medicine and of Medical Microbiology and Immunology
Creighton University School of Medicine
Omaha, Nebraska
Emily A. Blumberg
Division of Infectious Diseases
Department of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
Henry M. Blumberg
Division of Infectious Diseases
Emory University School of Medicine
Atlanta, Georgia
Barbara A. Brown-Elliott
Department of Microbiology
The University of Texas Health Science Center
Tyler, Texas
Emmanuelle Cambau
Centre National de Référence pour la résistance des Mycobactéries aux
antituberculeux
Laboratoire de Bactériologie, AP-HP Hôpital Lariboisière
Université Paris Diderot, IAME UMR 1137 INSERM
Paris, France
Juan Carlos Cataño
Section of Infectious Diseases
University of Antioquia Medical School
Medellín, Colombia
Leslie Chiang
Division of Tuberculosis Control
British Columbia Centre for Disease Control
Vancouver, British Columbia, Canada
Eric H. Choi
University of California Riverside School of Medicine and
Riverside Medical Clinic
Riverside, California
Amit Chopra
Division of Pulmonary and Critical Care Medicine
Albany Medical College
Albany, New York
Contributors xiii
Terence Chorba
Division of Tuberculosis Elimination
Centers for Disease Control and Prevention
Atlanta, Georgia
L. W. Preston Church
Ralph H. Johnson VA Medical Center
Charleston, South Carolina
Walter J. Coyle
Scripps Clinic Torrey Pines
La Jolla, California
John A. Crocco
UMDNJ—Robert Wood Johnson Medical School
New Brunswick, New Jersey
Charles L. Daley
Division of Mycobacterial and Respiratory Infections
National Jewish Health
Denver, Colorado
Thomas M. Daniel
Department of Medicine
Case Western Reserve University
University Hospitals Case Medical Center
Cleveland, Ohio
Arthur M. Dannenberg, Jr.
Department of Environmental Health Sciences
Department of Molecular Microbiology and Immunology
Department of Epidemiology
Johns Hopkins Bloomberg School of Public Health
Department of Pathology
Center for Tuberculosis Research
Johns Hopkins School of Medicine
Baltimore, Maryland
Bappaditya Dey
Center for Tuberculosis Research
Johns Hopkins School of Medicine
Baltimore, Maryland
Howard Hughes Medical Institute
Chevy Chase, Maryland
Thomas E. Dobbs
Mississippi State Department of Health
University of Mississippi Medical Center
Jackson, Mississippi
Claudia C. Dobler
Liverpool Hospital and South Western Sydney Clinical School
University of New South Wales
Woolcock Institute of Medical Research
xiv Contributors
University of Sydney
Sydney, New South Wales, Australia
Kelly E. Dooley
Johns Hopkins University School of Medicine
Divisions of Clinical Pharmacology & Infectious Diseases
Center for Tuberculosis Research
Baltimore, Maryland
Asim K. Dutt
Department of Medicine
Meharry Medical College
Nashville, Tennessee
Kevin Elwood
Division of Tuberculosis Control
British Columbia Centre for Disease Control
Vancouver, British Columbia, Canada
Jaime Esteban
Department of Clinical Microbiology
IIS-Fundación Jiménez Díaz, UAM
Madrid, Spain
André A. Figueiredo
Núcleo Interdisciplinar de Pesquisa em Urologia and Department of Surgery/Urology
Federal University of Juiz de Fora
Minas Gerais, Brazil
Jane M. Gould
Department of Pediatrics
Drexel University College of Medicine
Philadelphia, Pennsylvania
David E. Griffith
Heartland National TB Center
University of Texas Health Science Center-UT Health Northeast
San Antonio, Texas
Connie A. Haley
Division of Infectious Diseases and Southeast National Tuberculosis Center
University of Florida
Gainesville, Florida
Jonathan M. Hand
Department of Infectious Diseases
Ochsner Clinic Foundation
The University of Queensland School of Medicine
Ochsner Clinical School
New Orleans, Louisiana
Michael K. Hill
Saint Tammany Parish Hospital
Covington, Louisiana
Contributors xv
Carla Jeffries
Division of Tuberculosis Elimination
Centers for Disease Control and Prevention
Atlanta, Georgia
Aditya Jindal
Jindal Clinics
Chandigarh, India
Surinder K. Jindal
Department of Pulmonary Medicine
Postgraduate Institute of Medical Education & Research
Jindal Clinics
Chandigarh, India
James C. Johnston
Division of Tuberculosis Control
British Columbia Centre for Disease Control
Vancouver, British Columbia, Canada
Marc A. Judson
Division of Pulmonary and Critical Care Medicine
Albany Medical College
Albany, New York
Gregory C. Kane
Department of Medicine
Sidney Kimmel Medical College
The Korman Lung Center
Thomas Jefferson University
Philadelphia, Pennsylvania
Ijaz Kashef
Division of Global Health Protection
Centers for Disease Control and Prevention
Atlanta, Georgia
Won-Jung Koh
Division of Pulmonary and Critical Care Medicine
Department of Medicine
Samsung Medical Center
Sungkyunkwan University School of Medicine
Seoul, South Korea
Timothy Lahey
Dartmouth’s Geisel School of Medicine
Section of Infectious Diseases and International Health
Dartmouth-Hitchcock Medical Center
The Dartmouth Institute for Clinical Practice & Health Policy
Lebanon, New Hampshire
Gabriella S. Lamb
Baylor College of Medicine
Houston, Texas
xvi Contributors
Alfred A. Lardizabal
New Jersey Medical School Global Tuberculosis Institute
Rutgers University
Newark, New Jersey
John M. Leonard
Department of Medicine—Infectious Disease
Vanderbilt University Medical Center
Nashville, Tennessee
Michael K. Leonard, Jr.
Division of Infectious Diseases
Carolinas HealthCare System
Charlotte, North Carolina
James H. Lewis
Division of Hepatology
Department of Medicine
Georgetown University Hospital
Washington, DC
Phil LoBue
Division of Tuberculosis Elimination
Centers for Disease Control and Prevention
Atlanta, Georgia
Antônio M. Lucon
Division of Urology
University of São Paulo Medical School
São Paulo, Brazil
Sarah M. Lyon
Pulmonary, Allergy and Critical Care Division
Department of Medicine
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
Alberto Matteelli
Department of Infectious and Tropical Diseases
WHO Collaborating Centre for TB/HIV and TB Elimination
University of Brescia
Brescia, Italy
G. Shelton McMullan
Division of Gastroenterology
Georgetown University Hospital
Washington, DC
Jay B. Mehta
Department of Medicine
East Tennessee State University
James H. Quillen College of Medicine
Johnson City, Tennessee
Contributors xvii
Beverly Metchock
Division of Tuberculosis Elimination
Centers for Disease Control and Prevention
Atlanta, Georgia
Alladi Mohan
Division of Pulmonary and Critical Care Medicine
Department of Medicine
Sri Venkateswara Institute of Medical Sciences
Tirupati, India
Faiza Mougari
Centre National de Référence pour la résistance des Mycobactéries aux
antituberculeux
Laboratoire de Bactériologie, AP-HP Hôpital Lariboisière
Université Paris Diderot, IAME UMR 1137 INSERM
Paris, France
Maria-Carmen Muñoz-Egea
Department of Clinical Microbiology
IIS-Fundación Jiménez Díaz, UAM
Madrid, Spain
George A. Pankey
Department of Infectious Diseases
Ochsner Clinic Foundation
New Orleans, Louisiana
Charles Peloquin
Infectious Disease Pharmacokinetics Lab
College of Pharmacy
Emerging Pathogens Institute
University of Florida
Gainesville, Florida
Julie V. Philley
Department of Medicine
The University of Texas Health Science Center
Tyler, Texas
Laurel C. Preheim
Infectious Diseases Section
VA Medical Center
Departments of Medicine and of Medical Microbiology and Immunology
Creighton University School of Medicine
Omaha, Nebraska
Gary W. Procop
Department of Laboratory Medicine
Cleveland Clinic
Cleveland, Ohio
Meisha L. Raven
Department of Ophthalmology and Visual Sciences
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin
xviii Contributors
Florence Reibel
Centre National de Référence pour la résistance des Mycobactéries aux
antituberculeux
Sorbonne Université
Université Pierre et Marie Curie
AP-HP Hôpital Pitié-Salpêtrière
Centre d’Immunologie et des Maladies Infectieuses, Team 13, INSERM U1135
Paris, France
Lee B. Reichman
New Jersey Medical School Global Tuberculosis Institute
Rutgers University
Newark, New Jersey
Blanca I. Restrepo
UT Health Houston
School of Public Health at Brownsville
Brownsville, Texas
Jaime Robledo
Section of Mycobacteria Research
Corporación para Investigaciones Biológicas
Universidad Pontificia Bolivariana
Medellín, Colombia
Milton D. Rossman
Pulmonary, Allergy and Critical Care Division
Department of Medicine
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
Palash Samanta
University of Pittsburgh Medical Center
Infectious Diseases Section
Pittsburgh, Pennsylvania
Charles V. Sanders
Department of Medicine
Louisiana State University School of Medicine
New Orleans, Louisiana
David Schlossberg
The Lewis Katz School of Medicine at Temple University
The Perelman School of Medicine at the University of Pennsylvania
Philadelphia Department of Public Health
Philadelphia, Pennsylvania
Barbara J. Seaworth
Heartland National TB Center
University of Texas Health Science Center-UT Health Northeast
San Antonio, Texas
Contributors xix
Sorana Segal-Maurer
The Dr. James J. Rahal Jr. Division of Infectious Diseases
NewYork-Presbyterian/Queens
Flushing, New York
Weill Cornell Medicine
New York, New York
Surendra K. Sharma
Division of Infectious Diseases
Department of Medicine
All India Institute of Medical Sciences
New Delhi, India
Alan D.L. Sihoe
Department of Surgery
Li Ka Shing Faculty of Medicine
The University of Hong Kong
Hong Kong SAR, China
José Tiago Silva
University Hospital 12 de Octubre
Unit of Infectious Diseases
Madrid, Spain
Nina Singh
University of Pittsburgh Medical Center
Infectious Diseases Section
VA Pittsburgh Healthcare System and University of Pittsburgh
Pittsburgh, Pennsylvania
Giovanni Sotgiu
Clinical Epidemiology and Medical Statistics Unit
Department of Biomedical Sciences
University of Sassari
Sassari, Italy
Miguel Srougi
Division of Urology
University of São Paulo Medical School
São Paulo, Brazil
Jeffrey R. Starke
Baylor College of Medicine
Houston, Texas
Giorgia Sulis
Department of Infectious and Tropical Diseases
WHO Collaborating Centre for TB/HIV and TB Elimination
University of Brescia
Brescia, Italy
xx Contributors
Jeffrey A. Tornheim
Johns Hopkins University School of Medicine
Division of Infectious Diseases
Baltimore, Maryland
Urvashi Vaid
Department of Pulmonary and Critical Care Medicine
Thomas Jefferson University
Philadelphia, Pennsylvania
Christopher Vinnard
The Public Health Research Institute Center and Department of Medicine
New Jersey Medical School
Rutgers, The State University of New Jersey
Newark, New Jersey
C. Fordham von Reyn
Dartmouth’s Geisel School of Medicine
Section of Infectious Diseases and International Health
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Risa M. Webb
Division of Infectious Disease
University of Mississippi Medical Center
Mississippi State Department of Health
G.V. “Sonny” Montgomery VA Medical Center
Jackson, Mississippi
Dominik Zenner
Centre for Infectious Disease Surveillance and Control
Public Health England
Institute for Global Health
University College London
London, United Kingdom
Preface
xxi
xxii Preface
addition to the new chapters, every chapter has been thoroughly updated. New
clinical data impact our understanding of interferon gamma release assays, the
HIV-tuberculosis interaction, immune reconstitution inflammatory syndrome,
and extremely drug-resistant tuberculosis. The protean presentations of pulmo-
nary and extrapulmonary tuberculosis continue to challenge the clinician, as does
the growing list of nontuberculous mycobacterial pathogens. Epidemiologic is-
sues include airline-associated infection, the explosion of tuberculosis in areas of
the developing world, and the critical roles of the World Health Organization and
departments of public health in tuberculosis control.
We hope that this text continues to provide a complete and user-friendly re-
source for everyone—clinician, scientist, epidemiologist—involved in the diagno-
sis and treatment of tuberculosis and related infections.
I am grateful for the guidance, wisdom, and professionalism of the staff at
ASM Press, particularly Christine Charlip, Megan Angelini, and Greg Payne.
I
Another random document with
no related content on Scribd:
been proposed as theoretically useful. Sedatives, like aconite,
conium, digitalis, veratrum viride, ipecacuanha, and tartar emetic are
useful, either alone if pain be absent or combined with opiates if the
patient is suffering. Dover's powder or tartar emetic and morphia in
small doses was formerly in general use. If there be a disposition to
nausea the substitution of aconite for antimony is of great value. A
combination of morphia, bromide of potassium, and chloral hydrate
often gives excellent results. Paraldehyde may be preferable to
chloral by reason of its more thoroughly sedative effect. Derivative
measures—mercurial cathartics, cupping, leeching, or even general
bleeding—may become necessary in certain cases. After the acute
stage is passed blisters behind the ears should be employed. In the
sleeplessness of acute mania Newington28 has used mustard baths
with great satisfaction.
28 Brain, vol. i. p. 126.
Coma.
Lethargy.
A pathological variety of sleep, in which the repose of the body is
even more complete than in coma. The victim of coma often
presents a countenance suffused with blood; the pulse beats
vigorously, and respiration may become stertorous. But in lethargy
the abolition of bodily movements is almost total. In the milder forms
of this disorder the patient may be partially roused, so as to attempt
an answer when addressed, appearing like a person in very
profound sleep; but in the majority of cases he remains insensible,
unconscious, and utterly irresponsive to ordinary forms of irritation.
Respiration and circulation are reduced to a minimum, even
becoming for a time imperceptible. Uncomplicated with hysteria, the
disorder is rapidly fatal, but according to Rosenthal32 hysterical
lethargy is never mortal.
32 Real Encyc. der ges. Heilkunde, vol. viii. p. 276.
Apparent Death.
Lucid Lethargy.
Many similar narratives have been duly authenticated, but the limits
of the present article will not permit a discussion which properly
belongs to an investigation of the phenomena of trance. The
important fact for present consideration is the persistence of
conscious life despite the appearance of death. In this preservation
of consciousness, notwithstanding temporary suspension of certain
forms of sensibility, together with loss of the power of voluntary
motion, may be discovered a relationship between the events of
lucid lethargy and various somnambulic modifications of sleep which
have been previously passed in review.
Heat-Exhaustion.
Any one who has been long exposed to a high temperature under
circumstances requiring physical exertion must have noticed the
feeling of general weakness and relaxation which results. Thus far
reaches our every-day experience, but cases in which acute
symptoms are severe enough to cause alarm occur, although
somewhat infrequently. The attack may come on slowly, but may be
as abrupt as that of true sunstroke, and the severest cases may
happen in those who have been in robust health as well as in the
weak and feeble. The mind is usually clear, the pulse rapid and
feeble, the surface cool, the voice very weak, muscular strength
greatly lessened, and the feeling of exhaustion extreme. If this
condition be intensified, syncope may be developed with its usual
symptoms. In all this there is nothing peculiar and little that is
necessary to notice here; but there is a form of heat-exhaustion in
which the heart does not seem to suffer principally, but in which there
is collapse with palsy of the vaso-motor system, great fall of the
bodily temperature, and marked general nervous symptoms. At the
International Exhibition of 1876 a very powerful man, whilst working
in an intensely hot, confined space, fell down without giving warning,
and was brought into the hospital. He was in a state of restless,
delirious unconsciousness, incessantly muttering to himself, and
when shaken and shouted at responding only by a momentary grunt.
The pulse was rapid, fluttering and feeble. The surface was covered
with a very heavy sweat and exceedingly cold. The muscular
relaxation was extreme. The facies was that of collapse, and the
temperature, as taken in the mouth, 95.25° F.
The PATHOLOGY of heat-exhaustion is best discussed in conjunction
with that of thermic fever, and will therefore be for the present
postponed.
Thermic Fever.
SYNONYMS.—Coup de soleil, Sunstroke, Heat apoplexy, Heat
asphyxia, Heat fever, Sun fever, Thermohæmia, Erethismus tropicus,
Insolation.
Until very recently the existence within the United States of this class
of cases has not been recognized. But in a very able article in the
Therapeutic Gazette of March 16, 1885, John Guiteras shows that
the so-called typhoid fever of Key West is the disease described by
Morehead.
Thermic fever in the adult and in this latitude is usually first seen by
the physician after the stage of insensibility has been reached. In
many cases this condition comes on with great suddenness, but in
other instances there are distinct prodromata, such as inaptitude and
disinclination to exertion, vertigo, headache, confusion of ideas,
great oppression or distress at the præcordia or epigastrium, and
disturbances of the special senses. Swift has noticed a peculiar
chromatopsia, the sufferer seeing everything of a uniform color, in
most cases blue or purple, but in others red, green, or even white,
and W. H. Kesteven3 has reported a case in which a man, after
exposure to an excessively hot sun, was seized with severe
headache, saw everything red or green, and had for some days a
distinctly impaired color-sense.
3 Trans. Clin. Soc. of London, 1882, xv. 101.
About 1869, Eulenberg and Vohl9 advanced the theory that death
from sunstroke is the result of the sudden liberation of gases in the
blood; and Weikard affirmed that the death is due to the increase of
the coagulability of the blood and consequent formation of clots in
the vessels, being in this supported by Richardson of London.10
Contrasting with these in its being really an important contribution is
the article of Vallin:11 its chief merit is the conception of the idea of
the local heating of isolated parts of the body, and the devising of a
plan for carrying the idea into effect. The experiments of Vallin did
not themselves prove very much, and led him to the erroneous
conclusion, first, that the death in sunstroke is the result either of a
coagulation of the left ventricle or else of a disturbance of the
innervation of the heart by an action of the heat upon the nerve-
centres in the base of the brain; second, that these two forms of
death correspond to sthenic and asthenic varieties of insolation—
varieties which, I believe, have no proper existence.
9 Virchow's Archiv, t. lxii.
10 St. Bartholomew's Reports, vol. vii.
The above historical sketch shows that by many authors the relation
of sunstroke to fever had been more or less dimly perceived, and
that George B. Wood had very clearly stated the true nature of the
affection, in that it was simply the result of the direct action of heat.
Such statement, however, not resting upon proof, had not been
accepted: it was also wanting in detail, and where such details were
attempted the surmises were not always correct. Under these
circumstances my researches, made in 1870 and 1871, and first
published in 1872, led to the complete understanding of the
affection.
The space allotted to me in the present volume will not allow of any
detailed account of my experiments, but I shall quote from my
summing up of the results obtained by them. It was shown that
sunstroke may be produced in animals as readily as in man either by
natural or artificial heat; that the symptoms are similar to those seen
in man; that death takes place ordinarily by asphyxia; that after death
the characteristic lesions are alteration of the blood and rigidity of the
heart, with immediate or quickly-appearing post-mortem rigidity of
the general muscular system; that this rigidity of the heart comes on
in most cases after, not before, death, and is a result, not cause, of
death; that post-mortem rigidity is dependent upon coagulation of
myosin, and that the rigidity of the heart is of similar origin,
coagulation of the muscle-plasma occurring almost instantaneously
at 115° F., a degree almost attained in sunstroke; that when a
muscle has been in great activity immediately before death, myosin
coagulates at a much lower temperature, and that the cases of
sudden cardiac death occurring in battle among the East Indian
English troops were no doubt due to the coagulation of the heart's
myosin; that heating the brain of a mammal produces sudden
insensibility, with or without convulsions, at a temperature of 108° F.,
and death when a temperature of 113° is reached; that this effect of
the local application of heat is not due to induced congestion, but is
the result of the direct action of the heat upon the cerebrum, and that
consequently the nerve-centres are as perniciously affected by high
temperature as the muscles are; that the nerve-trunks bear a
temperature of 125° F. without their conducting power being
immediately affected; that whilst the general symptoms induced by
heating the brain of a rabbit are very different from those of
sunstroke, the nervous symptoms are exactly similar; that the life of
the blood is not destroyed by any temperature reached in sunstroke,
the amœboid movements of the white blood-cells and the absorption
power of the red disks not being injured; that the amount of oxygen
of the blood is greatly lessened, as the result of gradual asphyxia
combined with abnormal consumption of oxygen; that there is no
reason for believing that capillary thrombi are common in sunstroke;
that there is no specific poison developed in the blood; that the
deterioration of the vital fluid is due to the rapid tissue-changes
induced by the fever and the more or less complete arrest of
excretion; that such deterioration is secondary to the nervous
symptoms, not primary; that if the heat be withdrawn before it has
produced permanent injury to the nervous system, blood, or other
tissues, the convulsions and unconsciousness are immediately
relieved and the animal recovers.
It is of course possible that the external heat causes the fever, simply
by preventing the body from throwing off the caloric which it is
constantly forming. The extreme suddenness of the onset, however,
indicates that in at least many cases there is a sudden outburst, as it
were, in the production of heat in the body. This indication becomes
more important when it is remembered that in cerebral rheumatism,
so called, there is often an equally sudden attack of symptoms
plainly the result of a sudden production of animal heat.